The information within this section of the website is intended for patients prescribed Emerade. If you are not a patient choose from the following options:.
I am a member of the public. I am a Healthcare Professional.

Emerade is subject to Class 1 Product Recall by the manufacturer Pharmaswiss Česka republika s.r.o. For more details please follow the link below:

https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-emerade-500-micrograms-and-emerade-300-micrograms-auto-injectors-due-to-the-potential-for-device-failure-natpsa-slash-2023-slash-004-slash-mhra

  • How to use Emerade

How to
Use your
Emerade

Removing of the needle shield in pen

Remove needle shield

Pressing against the outer thigh

Press against the OUTER THIGH

Hold for 5 seconds

Hold for 5 seconds

Massage the injection site gently, then call 999, ask for an ambulance stating "Anaphylaxis". Avoid any sudden change in position, and do not stand up, even if you are feeling better

Feet raised

While waiting for the ambulance, lie flat with your feet up unless it makes it difficult for you to breathe

Sitting

In this case, sit up straight. Ask someone to stay with you until the ambulance arrives

Lyingdown

Unconscious patients should be placed on their side in the recovery position. Avoid any sudden change in position, and do not stand up, even if you are feeling better


An activated Emerade® cannot be used again. If your symptoms do not improve or get worse within 5 to 15 minutes of the first injection, you or your companion should use a second pre-filled pen. Therefore, you must always have two Emerade® pre-filled pens with you.


Your dose will be decided by your doctor depending on your bodyweight.

Emerade® is for single use only. However, in the absence of clinical improvement a second injection of Emerade® may be administered 5 -15 minutes after the first injection.

It is therefore recommended that you consult with your doctor to carry one or more Emerade®.

For full dosage information please refer to the Patient Information Leaflet.


How to
Check your
Emerade

HOW TO VERIFY THAT YOUR PRE-FILLED PEN HAS BEEN RELEASED AND ADRENALINE INJECTED

After using the Emerade according to the instructions, you can check that your pre-filled pen has been activated. The pictures apply to all dosages of Emerade.

The unused Emerade pre-filled pen (before activation) has the needle cover in normal position.

Unused Emerade pre-filled pen

The unused Emerade pre-filled pen (before activation) has the needle cover in normal position.

Activation of the Emerade pre-filled pen

After activation of the Emerade pre-filled pen, the needle cover is extended.

If the needle cover is not extended, the pre-filled pen has not activated.

The arrow on the label shows where the label can be lifted to reveal the viewing window

The arrow on the label shows where the label can be lifted to reveal the viewing window.

If the viewing window still shows a clear, colourless liquid (adrenaline solution), the prefilled pen did not deliver the dose of adrenaline successfully.

When Emerade has successfully delivered an adrenaline dose it shows a coloured plunger in the viewing window (visible by lifting the label).

Emerade® 150 micrograms pen Emerade® 150 micrograms:
Yellow viewing window after activation of the pre-filled pen and adrenaline injection
Emerade® 300 micrograms pen Emerade® 300 micrograms:
Green viewing window after activation of the pre-filled pen and adrenaline injection
Emerade® 500 micrograms pen Emerade® 500 micrograms:
Blue viewing window after activation of the pre-filled pen and adrenaline injection

If your Emerade has not activated, you must immediately press the pre-filled pen again with increased force against the outside of your thigh. If this injection was also unsuccessful, use the second pre-filled pen immediately.

If you suspect that an Emerade pre-filled pen has not worked properly, take it to a pharmacy so that it can be reported and examined.